Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes

Area of Science:

• Neuroimmunology
• Virology
• Immunology

Background:

• Astrocytes are crucial for neuronal function and astrocytosis is an early event in central nervous system (CNS) AIDS.
• Human immunodeficiency virus type 1 (HIV-1) gp41 contains an immunodominant domain.
• Antibodies targeting HIV-1 can potentially cross-react with host tissues.

Purpose of the Study:

• To investigate potential cross-reactivity between antibodies against HIV-1 gp41 and central nervous system (CNS) astrocytes.
• To explore the implications of this cross-reactivity in the context of CNS AIDS pathology.

Main Methods:

• Monoclonal antibodies were generated against a synthetic peptide of HIV-1 gp41 (amino acids 598-609).
• These antibodies were used to probe human and rodent CNS tissue for reactivity with astrocytes.
• A 43-kDa protein in CNS tissue preparations was identified as the binding target.
• Cerebrospinal fluid (CSF) from AIDS patients with CNS complications was analyzed for anti-astrocyte antibodies.

Main Results:

• Monoclonal antibodies against HIV-1 gp41 peptide reacted with astrocytes in human and rodent CNS tissue.
• The antibodies bound to a 43-kDa protein in CNS preparations, indicating a shared epitope.
• Anti-astrocyte antibodies with cross-reactivity to gp41 were detected in CSF of some AIDS patients with CNS issues.

Conclusions:

• HIV-1 gp41 shares a common epitope with astrocytes.
• Immune responses to HIV-1 gp41 may produce antibodies cross-reactive to astrocytes.
• Antibody-mediated effects on astrocytes could contribute to neuronal dysfunction in CNS AIDS.